Biblio
Export 1 results:
Author Title Type [ Year] Filters: Author is Alzheimer's Disease Cooperative Study Steering Committee [Clear All Filters]
“Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 311-21, 2014.
,